Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

3 Small-Caps That Might Be Acquisition Candidates

TheMotleyFool

0 0

3 Small-Caps That Might Be Acquisition Candidates

A lot of small biotechs are fantastic buys right now. With Big Pharma sitting on a lot of cash, we might start seeing some smart acquisitions later this year.

We asked a trio of contributors to pick the biotechs they're feeling most bullish about as potential buyout candidates in 2022. Their choices: OptimizeRx (NASDAQ: OPRX), Affimed (NASDAQ: AFMD), and Blueprint Medicines (NASDAQ: BPMC).

Image source: Getty Images.

Source Fool.com

Like: 0

OPRX

Share